Research - News
The iKnife, a revolutionary mass spectrometry method, contributes to precision surgery by allowing accurate identification of cancer margins.
The ecRNAs appear to act in memory formation, and may offer a new therapeutic approach to neuropsychiatric diseases.
The program is the first of its kind to incorporate research and medical training in genomics.
The biomarker, the protein kinase LRRK2, is a promising candidate for future exploration.
UAB study says laundry pod detergents pose an increased risk of severe injury for young children over nonpod detergents.
A potent compound discovered by UAB researchers in Antarctic waters could be a new weapon against a bacterial infection that kills thousands each year.
The Top 25 award program, presented by the UAB National Alumni Society, is designed to identify, recognize and celebrate the success of alumni business leaders.
A survival advantage for female humans stands out in a UAB review of sex differences in longevity across many species. Understanding why could inform treatments to extend healthy lifespans.
The new Kirklin Institute for Research in Surgical Outcomes positions UAB as a world leader in improving patient outcomes.
UAB’s Lung Health Center has joined the prestigious Airways Clinical Research Network established by the American Lung Association.
A robotic 3-D printer will build the tissue through computer-assisted design and computer-assisted manufacturing, but using living cells as the pieces of the structure.
Prostate cancer physicians look to provide personalized medicine to prostate cancer patients with a new medical device.
UAB is the first hospital in Alabama to implant a new electrical stimulator to combat sleep apnea and snoring.
Blacks are four times more likely than their white counterparts to die from stroke at age 45.
UAB has received a grant to develop and implement Ebola and infectious disease training to further protect health care and public safety workers.
Among black men, those with a high degree of West African genetic ancestry have less abdominal fat than those with a lower degree.
UAB is part of a national study aimed at teaching medical students the best ways to help their future patients maintain a healthy weight.
AIMTech’s ResistX treadmill will make its debut at the American College of Sports Medicine’s annual conference.
UAB researcher Sarah Parcak, Ph.D., has already shown the world how to find ancient sites from space. Now her graduate student is using remote sensing data to find a different kind of hidden treasure: uranium.
Cystic fibrosis lung cells were restored to 50 percent of healthy function in work that provides the first evidence that novel therapeutic strategies for human patients can be identified based on yeast studies.
UAB engineering professor Dean Sicking’s SAFER Barriers will be installed at the historic Le Mans Race Circuit.
Big data provides insight into patient readmission after pediatric neurosurgery.
Researchers from UAB, Emory and Microsoft demonstrate that HIV has evolved to be pre-adapted to the immune response, worsening clinical outcomes in newly infected patients.
UAB researchers will use a $1.8 million grant to look at single cells for altered expression of the interferon gamma receptor gene.
VA Research support for UAB clinicians and scientists has been important for six decades.
Longtime VP for Research and Economic Development Richard B. Marchase, Ph.D., plans to retire at the end of 2016. During his tenure, UAB annual research expenditures grew from $331 million to $510 million.
A treatment used for depression, Parkinson’s disease and autism shows promise to alleviate obesity in binge-eating disorder patients.
Results show that JAK/STAT pathway inhibitors may be a new class of therapeutic treatments for patients with Parkinson’s disease. Acting by reducing inflammation, they prevent neurodegeneration in animal models and may be an important new approach to slow progression of the disease.
Cutting-edge technology and research brings national attention to UAB.
Understanding how people respond to aspirin is key in terms of knowing who will benefit from it.